Abstract: Methods are provided which include converting oripavine to other opiates, including converting oripavine to naltrexone, buprenorphine, 14-hydroxymorphinone and/or converting 14-hydroxymorphinone to oxymorphone. Purification and salt formation are optionally included.

Abstract: Some embodiments relate to an integrated circuit (IC) including one or more finFET devices. A finFET includes a fin of semiconductor material extending upwards from a semiconductor substrate. First and second source/drain regions, which have a first doping type, are spaced apart laterally from one another in the fin. A channel region is disposed in the fin and physically separates the first and second source/drain regions from one another. The channel region has a second doping type opposite the first doping type. A conductive gate electrode straddles the fin about the channel region and is separated from the channel region by a gate dielectric. A shallow doped region, which has the first doping type, is disposed near a surface of the fin around upper and sidewall fin regions. The shallow doped region extends continuously under the gate electrode between outer edges of the gate electrode.

Abstract: A fabrication of natural cellulose fiber with flame-retarding capability comprises following steps. Blend pulp and solvent of N-methylmorpholine N-oxide (NMMO) to form slurry. Evaporate extra water content from slurry by a Thin Film Evaporator (TFE) to form dope. By Dry-Jet Wet Spinning, spin and extrude dope for coagulating and regenerating. Water-rinse and dry to form natural cellulose fiber. Soaking roll natural cellulose fiber by flame retardant of N-(hydroxymethyl)-3-(methoxy phosphorus acyl). Orderly dry, bake, neutralize, soaping clean, water rinse, baking dry, soaking rolled, alkaline clean, water rinse, dry and oil the natural cellulose fiber to produce natural cellulose fiber of flame retarding capacity. Because of cross-linking reaction for the flame retardant of N-(hydroxymethyl)-3-(methoxy phosphorus acyl) with natural cellulose fiber, the flame-retarding capability thereof meet requirements of testing standards in American ASTM D6413-1999 and ASTM D2863-1995.

Abstract: A Meltblown process for producing non-woven fabrics with flame-retarding capability from natural cellulose comprises following steps. Blend pulp and solvent of N-methylmorpholine N-oxide (NMMO) to form slurry. Evaporate water content from slurry by a Thin Film Evaporator to form dope. Extrude the dope off spinneret bank to form filament bundle via meltblown process. Coagulating regenerate, water rinse, hydro-entangled needle-punch and dry the filament bundle to form normal natural cellulose nonwoven. Soaking roll formed nonwoven by flame retardant of N-(hydroxymethyl)-3-(methoxy phosphorus acyl). Orderly dry, bake, neutralize, soaping clean, water rinse, baking dry, soaking roll, alkaline clean, water rinse, dry and coil the nonwoven to produce modified natural cellulose nonwoven of flame retarding capacity.

Abstract: The present invention provides a novel series of indeno[1,2-c]quinolin-11-one derivatives and further provides their preparation methods as well as applications. Said applications includes utilizing such derivatives as pharmaceutical compositions for treating cancers; moreover, said applications includes the capability possessed by such derivatives to effectively inhibit cancer cell growth as well as the activity of Type I topoisomerases and can be further applied for cancer treatment.

Abstract: The present invention provides a biphenyl benzamide-derived derivatives, which structure is selected from formula I or formula II and the synthesis and the application thereof.

Abstract: A method for forming an inorganic passivation material is provided. The method includes mixing about 5 to 80 parts by weight of trialkoxysilane, about 10 to 80 parts by weight of tetraalkoxysilane, and about 1 to 30 parts by weight of catalyst to perform a reaction at pH of about 0.05 to 4 to form an inorganic resin material. The inorganic resin material is modified by phosphate ester to form an inorganic passivation material, wherein phosphate ester is about 0.1-10 parts by weight based on 100 parts by weight of the inorganic resin material. An inorganic passivation material and a passivation protective film produced therefrom are also provided.

Abstract: A method of manufacturing a hydrophobic antifouling coating material, including: (a) mixing a sol-gel precursor, water, an aqueous colloidal silica suspension, and a catalyst to perform a sol-gel reaction to form a solution having particles therein, wherein the sol-gel reaction is performed without addition of any organic solvent; (b) chemically modifying the particles with a hydrophobic agent to form surface-modified particles; and (c) adding a surfactant to the solution containing the surface-modified particles to form a hydrophobic antifouling coating material. The hydrophobic antifouling coating material can be dispersed in an aqueous solution, and has properties such as low VOC (Volatile organic compound) value, high solid content, and high stability.

Abstract: A device, method, and optical machine-readable code for providing context-aware guidance for healthcare. The device includes: a wireless communication module configured to receive contextual information pertaining to a user's health from one or more devices; an optical code reader to read an optical code encoded with a plurality of healthcare guidance messages; a processor to decode the optical code encoded with the plurality of healthcare guidance messages into a selected context-aware healthcare guidance message using the received contextual information pertaining to the user's health; and a screen for providing the selected context-aware healthcare guidance message to the user. The optical machine-readable code including: an optical code storing a plurality of healthcare guidance messages and encoded in a manner that one of the plurality of healthcare guidance messages can be selected using a decode key, wherein the optical code is provided on a container for medication.

Abstract: A high transmittance thin film solar panel includes a transparent substrate, a front electrode layer, a light absorption layer and a rear electrode layer. The light absorption layer is formed with opening patterns with the same width at positions aligned correspondingly to form at least one first opening trench, a plurality of second opening trenches with continuously and periodically sinusoidal-wave shape, and a plurality of third opening trenches parallel to, interlace with or superpose the second opening trenches, and extend in a direction orthogonal to the direction of the first opening trench. The high transmittance thin film solar panel of the present invention is mainly used for green buildings. The opening trenches of the high transmittance thin film solar panel are formed in a manner of curve shape by oscillating laser head, can enhance the transmittance by more than about 3% in comparison with the conventional one.

Abstract: The disclosure provides an electronic paper display. The electronic paper display includes an electronic paper panel. A light guide plate is disposed on the electronic paper panel. The light guide plate has a first surface and a second surface opposite to the first surface. A conductive pattern structural layer is disposed on the light guide plate. A light source is disposed on a side of the light guide plate. The first surface of the light guide plate is a patterned surface. A light generated by the light source is reflected or scattered to the electronic paper panel by the patterned surface.

Abstract: The present invention provides a pharmaceutical composition of salicylanilide-derived small molecules include: (a) a compound which structure is selected from formula I or formula II: (b) a pharmaceutically acceptable salt and excipient. The present invention also provides the synthesis method of the pharmaceutical composition and the application thereof.

Abstract: The present invention relates to compounds of Formula (I): and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds inhibit Bcl-2 and/or Bcl-XL activities and may be used for the treatment of cancer.

Abstract: A multi-function garment includes an article of clothing and pockets disposed thereon. Each pocket includes an opening, a lining, and a two-sided engaging unit. The lining of one pocket includes a storage body of a ring-like configuration. The storage body has an open external vacancy interrupting the ring-like configuration of the storage body and an inner vacancy having one end closed and the other end communicating with the external vacancy. A dimension of the external vacancy is smaller than a dimension of the inner vacancy, and a protecting layer is disposed on an inner surface of the lining. Besides a wearing function of sheltering users' skin, the interior of the lining can be reversed outward to allow the article of clothing to be stuffed into the storage body, which is then converted into a neck pillow configuration for achieving the multiple function of using. The structure of the garment is also compact and easy to carry.

Abstract: A lithographic apparatus comprises a system. The system comprises a first part, a second part and an energy absorbing element. The second part is configured to move relatively to the first part. The system has a gap located between the first part and the second part during an operation mode of the system. The energy absorbing element is for absorbing energy between the first part and the second part when the first part and the second part crash onto each other in a failure mode of the system. The energy absorbing element is outside the gap.

Abstract: The present invention provides a biphenyl benzamide-derived derivatives, which structure is selected from formula I or formula II: and the synthesis and the application thereof.

Abstract: An illumination assembly is adapted to illuminate a display module that is visible by reflecting environmental lights. The illumination assembly includes a substrate, a visual-light source, and a light guide. The substrate includes a top surface. The visual-light source is disposed on the top surface and is provided for emitting a visual light. The light guide is disposed corresponding to the top surface of the substrate. The light guide includes a light-incidence surface and a light-emergence surface. The visual light enters the light guide through the light-incidence surface and is reflected at least once. The visual light then exits the light guide through the light-emergence surface and travels along a light-emergence direction.

Abstract: A touch panel including a first insulation substrate, a first conductive film, a first insulation film, first conductive wires, a second insulation substrate, a second conductive film, and second conductive wires is provided. The first conductive film is disposed on the first insulation substrate and the first insulation layer covers a portion of a periphery of the first conductive film so that the first conductive film has an exposed region. The first conductive wires are disposed on the periphery of the first conductive film and each of the first conductive wires includes an electrode segment and an extending segment. The electrode segment is electrically connected with the first conductive film and the extending segment is electrically isolated from the first conductive film. The second conductive film is disposed on the second insulation substrate. The second conductive wires are disposed on the periphery of the second conductive film.

Abstract: This disclosure relates to a method of recovering and concentrating an aqueous N-methylmorpholine-N-oxide (NMMO) solution.

Abstract: The invention provides a series of novel thiochromeno[2,3-c]quinolin-12-one derivatives. Further, the invention also provides the preparation method and application of said derivatives, said application comprises: said derivatives with treating effective amount are prepared into pharmaceutical compositions for inhibition of topoisomerase type I and II, inhibition of cancer cell growth, further treating cancer.